However, the increased expression of ACAN and HAS and the enhanced GAG synthesis in hNPCs of all donors by TD-198946 suggest that TD-198946 is a candidate therapeutic molecule for IDD. The gene discussed is ACAN; the disease is intervertebral disk degenerative disorder.